my name is peter bach, and i am a physician at the memorial sloan-kettering cancer center. this is a hybrid of techniques from economics, epidemiology, and statistics in order to gain an idea about the health care system. for more than one ticket, but my main interest has been health disparities. i am grateful for the invitation to speak to you today about my research and others. i am humbled by this opportunity, and for more than one decade, the national institute of aging, and many others, and specifically credit my colleagues at sloan- kettering and those at the center for health change. we have for together on these problems. the names of their peer are less relevant. about one decade ago, my colleagues and i wondered if the higher mortality rates with cancer could be due to blacks receiving less affected treatment, specifically in the setting of cancer. we chose a simple procedure. this was for early stage lung cancer. the streets the no. 1 cancer killer, lung cancer, 25% of all cancer deaths, and it is enormously effective. in an analysis printed one decade ago, prior

liz sloan wants health insurance but doesn't think she can afford it. we're assurant health, and we've been customizing plans to meet the needs of individuals for over 110 years. for instance, with our two-year rate guarantee and healthy discount, jeff will get 15% off his rate and lock in that rate for two years. for liz, we offer plans that allow people like her to pay for only the benefits they need, saving them money. in fact, liz could get up to $2 million of coverage for less than $100 per month. unlike other health insurance companies that focus on corporations and treat everyone the same, assurant health is there for the individual. so if you need health insurance, call the number on your screen, visit our website or contact your local agent. >> manny ramirez will return to the lienup for the dodgers this friday. after a brief layover in albuquerque. fans turned out in record numbers and sold out all the manny dreadlock wigs at $25, literally, a head. bryan, do you think manny will be receiving a hero's welcome when he visits the rest of the cou

>> there is a painting it as i came up from our offices of alfred sloane. i see paintings in our building in detroit and ask myself what he would do if in my shoes. he never was. but at the beginning of general motors there was a crisis. he did his job. he led the company through it. if you were sitting here today i imagine he would tell me to do my job. if i look at what my job is, yes, we have an interim chairman, kent. i am a believer in separating the chairman's role from the ceos role. i have my handful without running the board of directors. so i am very appreciative. working for kent is a pleasure and working for the board has been a pleasure. they are very hard-working. you heard the president. the only thing i can tell you is that the automotive task force has been rigorous in analysis but with no real interest in running our business. they told us we need to run our own business and they should hold us accountable. i am fine with that. i could not ask for a better environment. yes, it is different. but leaders in the past of general motors would d

peter bach who is a physician at the memorial sloan kiterring cancer center. his work has focused particularly on improving the quality of care for african-american patients in medicare including cancer care. he previously served as senior adviser to the administrator of the centers for medicare and medicaid services where among other things he oversaw the agency's cancer initiatives. folks, i am excited to have you here. this is an issue that is, that we've needed to have a fully flushed-out discussion on these issues for quite some time, and i'm glad you could make it here today. the next thing we have to take care of, we have to swear you in. so, please, raise your right hand. please swear or affirm that the information you have provided is true and accurate to the best of your knowledge and belief. >> i do. >> i do. >> very good. let's get started. here are the mechanics. each speaker will have 10 minutes, and, please, try to stay within the time frame. at the end of the, at the end of the presentations we will have a q&a session, and we will start with dr

. >> we are here at the lexington public library's branch with bob sloan. you often write short stories about life in appellation. tell about the true story that is accounted in the valley of the shadow. >> there was a feud in the county where i am from that occurred back in the 1880s and my grandfather -- my paternal grandfather, my dad's dad was born in 1877. the feud lasted about 1884 to 1887 depending on who you talk to. so i grew up hearing first hand accounts of some of this. my grandfather was friends with one of the principles of this thing. everybody knows about hatfield and mccoy and some of the other feuds. the round county viewed was absolutely the bloodiest and most significant of all of the east kentucky vendettas mountain view is. nobody knows about it. because when it was over, or when the worst part of it was over, a meeting was held after a day, one day, in which about ten people were killed. basically one side invaded morehead, kentucky and killed all of the leaders of the oversight. a meeting was held and people decided we won't talk abo

. >> stuart sloan. i have two questions. the first coming can you give some background on the hamas/if atop conversations that have been apparently unsuccessful in my second question has to do with what you just alluded to for american support for the piece process. the manifest that the u.s. government knows there is no palestinian right israel so therefore there is no real prospect in the future for any peace be yet the administration is pushing desperate right think you suggested a moment ago that the purpose of it as a fig leaf it is a charade that is going on to provide cover for the so-called moderate states. can you confirm that is your view? do you have any discussions with the administration? bereday aware this is an effort on their part? . .